GlassScriptPhysician profile
Miltiadis Leon
NPI 1558328690
$40,836.73
in general payments reported to CMS, 2019-2025
36 companies · $4,760 in 2025
The $4,760 reported for 2025 was more than what 82% of Interventional Cardiology providers received nationally (typical 2025 total: $1,092).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $16K · 2020: $5,013 · 2021: $3,278 · 2022: $1,929 · 2023: $6,807 · 2024: $2,935 · 2025: $4,760.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $11K · Travel and Lodging: $3,642.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $10,859.55 |
| Travel and Lodging | $3,641.77 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $5,909.85 | 2019-2025 | Jeti All In One Non-Sterile Kit, Diamondback Peripheral, Confirm Rx |
| Penumbra, INC. | $5,622.96 | 2023-2025 | Indigo System, Penumbra System |
| Bard Peripheral Vascular, INC. | $4,990.96 | 2019-2025 | Atlas |
| Medtronic Vascular, INC. | $4,029.65 | 2019-2020 | |
| Philips North America LLC | $3,960.75 | 2019-2025 | (Br5) Peripheral Ivus, (Bs0) Mechanical Atherectomy, IV Other |
| Veryan Medical Incorporated | $3,335.01 | 2021-2025 | Biomimics 3d Vascular Stent System |
| Cardiva Medical, INC. | $3,066.79 | 2019-2025 | Cardiva Vascade 6/7f Vcs, Cardiva Vascade Mvp Vvcs 6-12f, Optowire |
| Medtronic, INC. | $2,879.01 | 2021-2024 | Linq II, Silverhawk, Endurant Iis |
| Cardiovascular Systems INC. | $2,317.04 | 2019-2023 | Diamondback Peripheral |
| Impulse Dynamics (USA) INC. | $630.52 | 2023-2025 | Optimizer, Optimizer |
| Bolton Medical INC | $503.60 | 2023-2025 | Relay Thoracic Stent-Graft With Plus Delivery System, Glidesheath Slender, Access |
| Cardinal Health 200 LLC | $460.68 | 2020-2021 | |
| Biotronik INC. | $358.49 | 2020-2025 | Biomonitor, Amvia Edge, Renamic Neo |
| Angiodynamics, INC. | $328.58 | 2020-2025 | Auryon Laser System 100-120 Vac |
| Celonova Biosciences, INC. | $311.07 | 2019-2020 |
Show all 36 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals LP | $233.34 | 2019-2021 | |
| Edwards Lifesciences Corporation | $216.63 | 2024 | Sapien 3 Ultra Resilia |
| E.R. Squibb & Sons, L.L.C. | $205.32 | 2019-2022 | |
| Teleflex LLC | $198.60 | 2019-2024 | Manta, Trapliner |
| Imperative Care, INC | $192.84 | 2025 | Symphony Catheter, Prodigy Catheter |
| Cordis US Corp. | $181.81 | 2021-2024 | S.M.A.R.T., Zephyr |
| Siemens Medical Solutions USA, INC. | $126.49 | 2023 | Biograph Horizon-3r |
| Janssen Pharmaceuticals, INC | $125.14 | 2019-2023 | Xarelto |
| Tactile Systems Technology INC | $99.12 | 2022-2024 | Entre Plus, Flexitouch Plus |
| Abiomed | $98.98 | 2019 | |
| Boston Scientific Corporation | $85.56 | 2020-2024 | |
| Chiesi USA, INC. | $79.56 | 2019 | |
| Amarin Pharma, INC. | $53.42 | 2019 | |
| Reflow Medical INC | $43.89 | 2025 | |
| Novartis Pharmaceuticals Corporation | $43.88 | 2024 | |
| Merck Sharp & Dohme LLC | $32.56 | 2023 | Verquvo |
| Amgen INC. | $29.76 | 2022 | |
| Daiichi Sankyo INC. | $27.69 | 2024 | Injectafer |
| Bardy Diagnostics, INC. | $25.98 | 2020 | |
| Cook Medical LLC | $16.29 | 2020 | |
| Shockwave Medical, INC | $14.91 | 2023 | Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Miltiadis Leon listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.